Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-12-13 Purchase(A) | 2024-12-18 6:52 pm | Olema Pharmaceuticals Inc. | OLMA | Graham G. Walmsley Director | 700,761 | $6.75 | $4,730,137 | 1,408,875 (Indirect) | View |
| 2024-12-13 Sale(A) | 2024-12-18 6:52 pm | Olema Pharmaceuticals Inc. | OLMA | Graham G. Walmsley Director | 700,761 | $6.75 | $4,730,137 | 1,408,875 (Indirect) | View |
| 2024-12-17 Purchase | 2024-12-17 7:52 pm | Olema Pharmaceuticals Inc. | OLMA | Graham G. Walmsley Director | 700,761 | $6.75 | $4,730,137 | 1,408,875 (Indirect) | View |
| 2024-12-17 Sale | 2024-12-17 7:52 pm | Olema Pharmaceuticals Inc. | OLMA | Graham G. Walmsley Director | 700,761 | $6.75 | $4,730,137 | 1,408,875 (Indirect) | View |
| 2024-06-04 Sale(A) | 2024-11-26 4:48 pm | Olema Pharmaceuticals Inc. | OLMA | Graham G. Walmsley Director | 1,175,000 | $14.85 | $17,448,750 | 708,114 (Indirect) | View |
| 2024-06-04 Sale | 2024-06-06 5:01 pm | Olema Pharmaceuticals Inc. | OLMA | Graham G. Walmsley Director | 1,175,000 | $14.85 | $17,448,750 | 708,114 (Indirect) | View |
| 2023-09-12 Purchase | 2023-12-18 6:30 pm | Olema Pharmaceuticals Inc. | OLMA | Graham G. Walmsley Director | 640,000 | $10.74 | $6,871,279 | 4,383,875 (Indirect) | View |
| 2023-12-08 Purchase | 2023-12-11 9:06 pm | Akero Therapeutics Inc. | AKRO | Graham G. Walmsley Director | 100,000 | $19.83 | $1,982,940 | 802,168 (Indirect Direct) | View |
| 2023-11-30 Purchase | 2023-12-05 08:37 am | Akero Therapeutics Inc. | AKRO | Graham G. Walmsley Director | 100,000 | $16.95 | $1,694,565 | 702,168 (Indirect Direct) | View |
| 2023-08-08 Purchase | 2023-08-10 4:46 pm | Akero Therapeutics Inc. | AKRO | Graham G. Walmsley Director | 25,000 | $42.06 | $1,051,475 | 602,168 (Indirect Direct) | View |
| 2023-07-28 Purchase | 2023-08-01 7:52 pm | Akero Therapeutics Inc. | AKRO | Graham G. Walmsley Director | 55,000 | $42.95 | $2,362,234 | 577,168 (Indirect Direct) | View |
| 2022-09-19 Purchase(A) | 2023-06-15 9:26 pm | Akero Therapeutics Inc. | AKRO | Graham G. Walmsley Director | 520,000 | $29.69 | $15,440,000 | 522,168 (Indirect Direct) | View |
| 2023-05-19 Purchase | 2023-05-23 9:55 pm | Akero Therapeutics Inc. | AKRO | Graham G. Walmsley Director | 520,000 | $29.69 | $15,440,000 | 522,168 (Indirect Direct) | View |
| 2020-12-14 Purchase | 2020-12-15 7:07 pm | ALX ONCOLOGY HOLDINGS INC | ALXO | Graham G. Walmsley Director | 20,000 | $76 | $1,520,000 | 3,156,981 (Indirect) | View |
| 2020-11-23 Purchase | 2020-11-23 4:35 pm | Olema Pharmaceuticals Inc. | OLMA | Graham G. Walmsley Director | 1,160,000 | $19 | $22,040,000 | 1,160,000 (Indirect) | View |
| 2020-07-21 Purchase | 2020-07-21 8:04 pm | ALX ONCOLOGY HOLDINGS INC | ALXO | Graham G. Walmsley Director | 975,000 | $19 | $18,525,000 | 975,000 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-06-14 Option Award | 2024-06-18 5:00 pm | N/A 2034-06-14 | Olema Pharmaceuticals Inc. | OLMA | Graham G. Walmsley Director | 23,000 | $0 | 23,000 (Direct) | View |
| 2024-06-08 Option Award | 2024-06-11 5:29 pm | N/A 2034-06-07 | Akero Therapeutics Inc. | AKRO | Graham G. Walmsley Director | 26,000 | $0 | 26,000 (Direct) | View |
| 2023-06-23 Option Award | 2023-06-27 5:48 pm | N/A 2033-06-22 | Akero Therapeutics Inc. | AKRO | Graham G. Walmsley Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2023-06-16 Option Award | 2023-06-21 5:00 pm | N/A 2033-06-15 | Olema Pharmaceuticals Inc. | OLMA | Graham G. Walmsley Director | 21,520 | $0 | 21,520 (Direct) | View |
| 2022-06-17 Option Award(A) | 2022-06-27 5:10 pm | N/A 2032-06-16 | Olema Pharmaceuticals Inc. | OLMA | Graham G. Walmsley Director | 21,520 | $0 | 21,520 (Direct) | View |
| 2022-06-16 Option Award | 2022-06-17 7:25 pm | N/A 2032-06-15 | Olema Pharmaceuticals Inc. | OLMA | Graham G. Walmsley Director | 21,520 | $0 | 21,520 (Direct) | View |
| 2022-06-02 Option Award | 2022-06-03 4:06 pm | N/A 2032-06-01 | Akero Therapeutics Inc. | AKRO | Graham G. Walmsley Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2021-06-11 Option Award | 2021-06-15 7:03 pm | N/A 2031-06-10 | ALX ONCOLOGY HOLDINGS INC | ALXO | Graham G. Walmsley Director | 12,004 | $0 | 12,004 (Direct) | View |
| 2021-06-09 Option Award | 2021-06-10 6:38 pm | N/A 2031-06-08 | Olema Pharmaceuticals Inc. | OLMA | Graham G. Walmsley Director | 21,520 | $0 | 21,520 (Direct) | View |
| 2021-06-01 Gift | 2021-06-03 5:55 pm | N/A 2031-05-31 | Akero Therapeutics Inc. | AKRO | Graham G. Walmsley Director | 49,832 | $0 | 62,832 (Direct) | View |
| 2021-06-01 Option Award | 2021-06-03 5:55 pm | N/A 2031-05-31 | Akero Therapeutics Inc. | AKRO | Graham G. Walmsley Director | 13,000 | $0 | 62,832 (Direct) | View |
| 2020-11-23 Conversion | 2020-11-23 4:35 pm | N/A N/A | Olema Pharmaceuticals Inc. | OLMA | Graham G. Walmsley Director | 2,583,875 | $0 | 1,160,000 (Indirect) | View |
Ownership | 2020-11-20 7:06 pm | N/A N/A | Lifesci Acquisition II Corp. | LSAQ | Graham G. Walmsley Director | 0 | $0 | 6,000 (Direct) | View |
| 2020-11-18 Option Award | 2020-11-19 7:01 pm | N/A 2030-11-17 | Olema Pharmaceuticals Inc. | OLMA | Graham G. Walmsley Director | 64,560 | $0 | 1,587,252 (Direct) | View |
Ownership | 2020-11-18 6:41 pm | N/A N/A | Olema Pharmaceuticals Inc. | OLMA | Graham G. Walmsley Director | 0 | $0 | 2,583,875 (Indirect) | View |
| 2020-07-21 Conversion | 2020-07-21 8:04 pm | N/A N/A | ALX ONCOLOGY HOLDINGS INC | ALXO | Graham G. Walmsley Director | 2,105,901 | $0 | 975,000 (Indirect) | View |
| 2020-07-16 Option Award | 2020-07-17 7:10 pm | N/A 2030-07-16 | ALX ONCOLOGY HOLDINGS INC | ALXO | Graham G. Walmsley Director | 24,009 | $0 | 24,009 (Direct) | View |
Ownership | 2020-07-16 6:41 pm | N/A N/A | ALX ONCOLOGY HOLDINGS INC | ALXO | Graham G. Walmsley Director | 0 | $0 | 2,105,901 (Indirect) | View |
| 2020-06-01 Option Award | 2020-06-02 6:53 pm | N/A 2030-05-31 | Akero Therapeutics Inc. | AKRO | Graham G. Walmsley Director | 13,000 | $0 | 13,000 (Direct) | View |
| 2019-11-08 Exercise | 2020-04-01 6:52 pm | N/A 2029-11-07 | Akero Therapeutics Inc. | AKRO | Graham G. Walmsley Director | 2,168 | $0 | 26,000 (Direct) | View |
| 2020-03-30 Exercise | 2020-04-01 6:52 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Graham G. Walmsley Director | 2,168 | $19.97 | 26,000 (Direct) | View |